Impact of Yogotherapeutics on Chronic Pains' Patients (YOGADO)

July 13, 2022 updated by: Centre Hospitalier René Dubos

Impact of Yogotherapeutics in Consultation on Chronic Pains' Patients

In a context where yoga is more and more popularized in France and in Europe, and where Yogatherapy (as complementary medicine) begins to make its place in the care of patients in French hospitals, it seems interesting to study the impact of yoga in the chronic pain patient treated in a specific pain consultation by this non-pharmacological approach, and accessible.

Study Overview

Status

Completed

Conditions

Intervention / Treatment

Detailed Description

Yoga is a discipline that has its origins in India for nearly 5,000 years, and which aims to bring physical, mental and spiritual well-being through postures, stretching, breathing exercises and meditation.

Non-invasive and having very few side effects, this approach allows the practitioner to reclaim their body, to know themselves better, to accept their limits, to respect them and to empower themselves in their care and pathology.

More and more studies are now looking at the positive effect of yoga whether it is on stress by demonstrating the drop in cortisol in participants, or on the reduction of symptoms of depression, improvement of immune function, or pain.

To our knowledge, no study of the impact of yoga for analgesic treatment has been carried out in France.

Through this retrospective study, the investigators wish to demonstrate a reduction in pain and / or an improvement in the quality of life.

Study Type

Observational

Enrollment (Actual)

40

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Pontoise, France, 95300
        • Departement of Chronic Pain Consultation, Hospital René Dubos,

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Sampling Method

Non-Probability Sample

Study Population

Patients seen in consultation for chronic pain and with prescription of Yogatherapy

Description

Inclusion Criteria:

  • Patient ≥ 18 years old,
  • Seen in consultation for chronic pain with implementation of Yogatherapy,

Exclusion Criteria:

  • Patient < 18 years old,
  • No indication for Yogatherapy treatment (Severe cognitive disorder / Major unbalanced psychological disorder),
  • Trauma pathology and / or acute fracture in progress,
  • Patient refusal to participate.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
Yogatherapy
Retrospective study on medical file of patients seen in consultation for chronic pain with prescription of Yogatherapy
Description: Retrospective study on medical file of patients seen in consultation for chronic pain with prescription of Yogatherapy

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Evolution of the patient's pain
Time Frame: Between the 1st and the 5th consultation, an average of 3 to 5 month
The evolution of the patient's pain is assessed by comparing the pain between the 1st and the 5th consultation, using a numerical scale from 0 to 10 points (0 = no pain and 10 = maximum pain imaginable)
Between the 1st and the 5th consultation, an average of 3 to 5 month

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Evolution of the patient's pain over time
Time Frame: Between the 1st and the 5th consultation, an average of 3 to 5 month
The evolution of the patient's pain is assessed by comparing the pain between the 1st and the last consultation (number 10 maximum), using a numerical scale from 0 to 10 points (0 = no pain and 10 = maximum pain imaginable)
Between the 1st and the 5th consultation, an average of 3 to 5 month
Improvement of patient's sleep
Time Frame: Between the 1st and the last consultation, an average of 5 to 10 month
The impact of pain on sleep is evaluated by questioning the patient at the first and last consultation (number 10 maximum) The answer to the question is YES or NO
Between the 1st and the last consultation, an average of 5 to 10 month
Evolution of the patient's quality of life
Time Frame: Between the 1st and the last consultation, an average of 5 to 10 month

The quality of life is assessed at all visits, by questioning patient, on the following elements: work, daily activities, mood…. to obtain a score on a numerical scale between 0 and 10

Results are interpreted as following : EN ≤ 5 = Very degraded, 6 ≥ EN ≤ 7 = Degraded and EN > 7 = Normal)

Between the 1st and the last consultation, an average of 5 to 10 month
Evolution of the patient's therapeutic
Time Frame: Between the 1st and the last consultation, an average of 5 to 10 month
The evolution of the therapeutic is evaluated by questioning the patient at the first and last consultation (number 10 maximum) about their treatment: treatment name, indication, dosage, number of doses per day, decrease or increase for each treatment ……. to see if there is a decrease or not in the patient's therapies.
Between the 1st and the last consultation, an average of 5 to 10 month

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Jocelyne BOREL-KUHNER, Hospital René Dubos,

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

September 13, 2021

Primary Completion (Actual)

June 28, 2022

Study Completion (Actual)

June 28, 2022

Study Registration Dates

First Submitted

December 3, 2021

First Submitted That Met QC Criteria

December 3, 2021

First Posted (Actual)

December 16, 2021

Study Record Updates

Last Update Posted (Actual)

July 14, 2022

Last Update Submitted That Met QC Criteria

July 13, 2022

Last Verified

April 1, 2022

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • CHRD1119

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Chronic Pain

Clinical Trials on Yogatherapy

Subscribe